On the one hand, the loss of E-cadherin expression is associated with tumor development, metastatic dissemination, and poor patient prognosis (Oka et al., 1993, Schipper et al., 1991, Umbas et al., 1994). The gene discussed is CDH1; the disease is neoplasm.